Close

Alexza Adasuve manufacturing facility wins EU Certificate of GMP Compliance

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Fluid Path Integrity: Ensuring Purity in Biomanufacturing

In the high-stakes arena of biomanufacturing, where tiny contaminants...

GMP Fluid Handling: Regulatory Compliance Explained

Fluid Handling in GMP Manufacturing: The Essence of Regulatory...

Single-Use Technologies in Biopharma Transform Manufacturing

The biopharmaceutical sector is being revolutionized by the demand...

Advances in Aseptic fluid transfer solutions

Sterility and Cross-Contamination: The Cornerstones of Modern Biopharma Manufacturing Biopharmaceutical...

Alexza Pharmaceuticals, a pharmaceutical company, has received EU Certificate of GMP Compliance for its Adasuve manufacturing facility.

In May 2012, Alexza hosted an EU GMP inspection, which was conducted by the Agencia Espanola de Medicamentos y Productos Sanitarios.

The Spanish authorities, on behalf of the EU, from the inspection of the company’s Mountain View, California facility and additional company responses, considered that the Alexza facility complies with the principles and guidelines of Good Manufacturing Practice set forth in Directive 2003/94/EC.

The initial certificate is valid through 15 May 2015, according to Alexza Pharmaceuticals. Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.

Latest stories